Literature DB >> 25870237

Recycled IL-7 Can Be Delivered to Neighboring T Cells.

Douglas A Bazdar1, Magdalena Kalinowska2, Soumya Panigrahi1, Scott F Sieg3.   

Abstract

IL-7 is a key homeostatic cytokine that provides signals for T cell survival and proliferation in vivo. In this article, we provide evidence that IL-7 utilization is enhanced by a novel mechanism of cytokine "recycling" during which T cells treated with rIL-7 are rapidly induced to express p-STAT5 and are subsequently able to recycle biologically active cytokine for release to neighboring cells in soluble form. Our observations indicate that the ability of cells to recycle IL-7 is dependent on IL-7R α-chain (CD127) and endocytosis, consistent with a model whereby IL-7 is internalized via receptor interactions before recycling. These observations provide evidence of a novel mechanism that enables cells to optimally use IL-7.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25870237      PMCID: PMC4417450          DOI: 10.4049/jimmunol.1400560

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Rab11 is associated with transferrin-containing recycling compartments in K562 cells.

Authors:  E G Green; E Ramm; N M Riley; D J Spiro; J R Goldenring; M Wessling-Resnick
Journal:  Biochem Biophys Res Commun       Date:  1997-10-20       Impact factor: 3.575

Review 2.  Interleukin-7 receptor expression: intelligent design.

Authors:  Renata Mazzucchelli; Scott K Durum
Journal:  Nat Rev Immunol       Date:  2007-02       Impact factor: 53.106

3.  Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis.

Authors:  L A Borghesi; Y Yamashita; P W Kincade
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

4.  Rab11-FIP3 binds dynein light intermediate chain 2 and its overexpression fragments the Golgi complex.

Authors:  Conor P Horgan; Sara R Hanscom; Rushee S Jolly; Clare E Futter; Mary W McCaffrey
Journal:  Biochem Biophys Res Commun       Date:  2010-03-07       Impact factor: 3.575

Review 5.  Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients.

Authors:  Silvia Giliani; Luigi Mori; Geneviève de Saint Basile; Francoise Le Deist; Carmen Rodriguez-Perez; Concetta Forino; Evelina Mazzolari; Sophie Dupuis; Ronit Elhasid; Aharon Kessel; Claire Galambrun; Juana Gil; Alain Fischer; Amos Etzioni; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

6.  Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.

Authors:  Douglas A Bazdar; Magdalena Kalinowska; Scott F Sieg
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

7.  Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.

Authors:  Yves Levy; Christine Lacabaratz; Laurence Weiss; Jean-Paul Viard; Cecile Goujard; Jean-Daniel Lelièvre; François Boué; Jean-Michel Molina; Christine Rouzioux; Véronique Avettand-Fénoêl; Thérèse Croughs; Stéphanie Beq; Rodolphe Thiébaut; Geneviève Chêne; Michel Morre; Jean-François Delfraissy
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

8.  IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.

Authors:  Irini Sereti; Richard M Dunham; John Spritzler; Evgenia Aga; Michael A Proschan; Kathy Medvik; Catherine A Battaglia; Alan L Landay; Savita Pahwa; Margaret A Fischl; David M Asmuth; Allan R Tenorio; John D Altman; Lawrence Fox; Susan Moir; Angela Malaspina; Michel Morre; Renaud Buffet; Guido Silvestri; Michael M Lederman
Journal:  Blood       Date:  2009-04-20       Impact factor: 22.113

9.  Decreased IL-7 responsiveness is related to oxidative stress in HIV disease.

Authors:  Magdalina Kalinowska; Douglas A Bazdar; Michael M Lederman; Nicholas Funderburg; Scott F Sieg
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

10.  Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.

Authors:  Claude Sportès; Frances T Hakim; Sarfraz A Memon; Hua Zhang; Kevin S Chua; Margaret R Brown; Thomas A Fleisher; Michael C Krumlauf; Rebecca R Babb; Catherine K Chow; Terry J Fry; Julie Engels; Renaud Buffet; Michel Morre; Robert J Amato; David J Venzon; Robert Korngold; Andrew Pecora; Ronald E Gress; Crystal L Mackall
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307

View more
  2 in total

1.  Targeting Cytokines in GVHD Therapy.

Authors:  Sandeep Kumar; Hemn Mohammadpour; Xuefang Cao
Journal:  J Immunol Res Ther       Date:  2017-06-28

Review 2.  Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.

Authors:  Pavan Kumar Dhanyamraju; Soumya Iyer; Gayle Smink; Yevgeniya Bamme; Preeti Bhadauria; Jonathon L Payne; Elanora Dovat; Morgann Klink; Yali Ding
Journal:  Int J Mol Sci       Date:  2020-02-18       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.